Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Labriola-Tompkins E"'
Autor:
Ju, G., Labriola-Tompkins, E., Campen, C. A., Benjamin, W. R., Karas, J., Plocinski, J., Biondi, D., Kaffka, K. L., Kilian, P. L., Eisenberg, S. P., Evans, R. J.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1991 Apr 01. 88(7), 2658-2662.
Externí odkaz:
https://www.jstor.org/stable/2356244
Autor:
Sivapalasingam S; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Lederer DJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Bhore R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Hajizadeh N; Institute for Clinical Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, New York, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, New York, USA., Criner G; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA., Hosain R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Mahmood A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Giannelou A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Somersan-Karakaya S; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., O'Brien MP; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Boyapati A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Parrino J; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Musser BJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Labriola-Tompkins E; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Ramesh D; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Purcell LA; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Gulabani D; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Kampman W; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Waldron A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Ng Gong M; Department of Medicine, Montefiore-Moses, Bronx, New York, USA., Saggar S; Department of Infectious Disease, Holy Name Medical Center, Teaneck, New Jersey, USA., Sperber SJ; Department of Infectious Disease, Hackensack Meridian School of Medicine and Hackensack University Medical Center, Hackensack, New Jersey, USA., Menon V; Department of Medicine, NYC Health + Hospitals/Lincoln, Bronx, New York, USA., Stein DK; Department of Medicine, Jacobi Medical Center, Bronx, New York, USA., Sobieszczyk ME; Department of Medicine, Columbia University, New York, New York, USA., Park W; Pulmonary and Sleep Disorder Clinic, Valley Medical Center, Renton, Washington, USA., Aberg JA; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USAand., Brown SM; Department of Internal Medicine, Intermountain Medical Center and University of Utah, Salt Lake City, Utah, USA., Kosmicki JA; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Horowitz JE; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Ferreira MA; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Baras A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Kowal B; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Thomas DiCioccio A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Akinlade B; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Nivens MC; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Braunstein N; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Herman GA; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Yancopoulos GD; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Weinreich DM; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Aug 24; Vol. 75 (1), pp. e380-e388.
Autor:
Dickinson M; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Briones J; Hematology Department, Hospital de la Santa Creu i Sant Pau, Sant Pau, Spain.; Jose Carreras Leukemia Research Institutes, Autonomous University of Barcelona, Barcelona, Spain., Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., González-Barca E; Department of Hematology, Institut Català d'Oncologia, Hospital duran i Reynals, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de LLobregat, Barcelona, Spain., Ghosh N; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC., Cordoba R; Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain., Rutherford SC; Meyer Cancer Center, Division of Hematology and Medical Oncology, Weill Department of Medicine, NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, NY., Bournazou E; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY., Labriola-Tompkins E; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY., Franjkovic I; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Chesne E; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Brouwer-Visser J; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY., Lechner K; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Brennan B; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY., Nüesch E; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., DeMario M; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY., Rüttinger D; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Kornacker M; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Hutchings M; Department of Hematology and.; Phase 1 Unit, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Publikováno v:
Blood advances [Blood Adv] 2021 Nov 23; Vol. 5 (22), pp. 4762-4770.
Autor:
Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. geoffrey_shapiro@dfci.harvard.edu., LoRusso P; Early Phase Clinical Trials Program, Yale University Medical Center, New Haven, CT, USA., Dowlati A; Department of Medicine-Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, USA., T Do K; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Vaishampayan U; Department of Oncology, Karmanos Cancer Institute, Detroit, MI, USA., Weise A; Medical Oncology, Karmanos Cancer Institute, Detroit, MI, USA., Caimi PF; Department of Medicine-Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Eder JP; Early Phase Clinical Trials Program, Yale University Medical Center, New Haven, CT, USA., French CA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Labriola-Tompkins E; Roche Pharma Research and Early Development, Roche Innovation Center New York, New York, NY, USA., Boisserie F; Roche Pharma Research and Early Development, Roche Innovation Center New York, New York, NY, USA., Pierceall WE; Roche Pharma Research and Early Development, Roche Innovation Center New York, New York, NY, USA., Zhi J; Roche Pharma Research and Early Development, Roche Innovation Center New York, New York, NY, USA., Passe S; Roche Pharma Research and Early Development, Roche Innovation Center New York, New York, NY, USA., DeMario M; Roche Pharma Research and Early Development, Roche Innovation Center New York, New York, NY, USA., Kornacker M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Feb; Vol. 124 (4), pp. 744-753. Date of Electronic Publication: 2020 Dec 14.
Autor:
Pieper, Nadja M.1 (AUTHOR), Schnell, Julia1 (AUTHOR), Bruecher, Daniela1 (AUTHOR), Knapp, Stefan2,3 (AUTHOR), Vogler, Meike1,3,4 (AUTHOR) m.vogler@kinderkrebsstiftung-frankfurt.de
Publikováno v:
Cell Communication & Signaling. 8/27/2024, Vol. 22 Issue 1, p1-15. 15p.
Publikováno v:
Inflammation: Mechanisms and Therapeutics ISBN: 9783034873451
Using site-directed mutagenesis, we have determined the location and composition of the binding sites in human IL-1 alpha and IL-1 beta for the Type I IL-1 receptor (IL-1R). The binding site in each ligand is a discontinuous epitope made up of at lea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6a7e730a05a00fdd9fd1f753805c195
https://doi.org/10.1007/978-3-0348-7343-7_14
https://doi.org/10.1007/978-3-0348-7343-7_14
Autor:
Dickinson, M., Briones Mejjide, J., Herrera, A.F., González Barca, E., Ghosh, N., Cordoba, R., Rutherford, S.C., Advani, R., Bournazou, E., Labriola‐Tompkins, E., Friess, T., Chesne, E., Brouwer‐Visser, J., Lechner, K., Brennan, B., Nueesch, E., De Mario, M., Hutchings, M.
Publikováno v:
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p174-175, 2p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ratan Y; Department of Pharmacy, Banasthali Vidyapith, Banasthali-304022, Rajasthan, India., Rajput A; Department of Pharmacy, Banasthali Vidyapith, Banasthali-304022, Rajasthan, India., Pareek A; Department of Pharmacy, Banasthali Vidyapith, Banasthali-304022, Rajasthan, India., Jain V; Department of Pharmaceutical Sciences, MLSU, Udaipur-313001, Rajasthan, India., Pareek A; Department of Pharmacy, Banasthali Vidyapith, Banasthali-304022, Rajasthan, India., Gupta MM; School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad & Tobago, WI., Kamal MA; Joint Laboratory of Artificial Intelligence in Healthcare, Institutes for Systems Genetics and West China School of Nursing, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.; King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.; Enzymoics, 7Peterlee place, Hebersham, NSW 2770, Novel Global Community Educational Foundation, Australia.
Publikováno v:
Current pharmaceutical biotechnology [Curr Pharm Biotechnol] 2024; Vol. 25 (9), pp. 1142-1166.
Autor:
Marcellin, P., Cooper, C., Balart, L.A., Larrey, D.G., Box, T.D., Yoshida, E., Lawitz, E., Buggisch, P., Ferenci, P., Weltman, M., Labriola-Tompkins, E., Le Pogam, S., Nájera, I., Thomas, D.N., Hooper, G., Shulman, N., Zhang, Y., Navarro, M.T., Lim, C.Y., Brunda, M., Yetzer, E.S., Terrault, N.
Publikováno v:
In Journal of Hepatology April 2012 56 Supplement 2:S472-S472